Mortality after Covid-19-related Mucormycosis in Critically ill Patients: A Systematic Review

Osquee, Hamid Owaysee; Lotfi, Ali Reza

doi:10.5281/zenodo.8214315

Mortality after Covid-19-related Mucormycosis in Critically ill Patients: A Systematic Review

Document Type : Review Article

Authors

Hamid Owaysee Osquee ¹

Ali Reza Lotfi ²

¹ Associate Professor of Infectious Disease, Department of Infectious Disease, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran

² Associate Professor of Otorhinolaryngology, Head and Neck Surgery, Tuberculosis and Lung Disease Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

https://doi.org/10.5281/zenodo.8214315

Abstract

Examining laboratory parameters to determine acute or less severe cases of mucormycosis after contracting covid-19, identifying patients who are at higher risk of mortality, and increasing awareness for proper practice will be useful in improving the clinical situation. So we decided to Investigate Factors Affecting Mortality From mucormycosis After Covid-19 Infection. Methods: This study was a systematic review (Conducted by PRISMA guideline). This study was conducted in Tabriz university of medical sciences in 2022. Results: From examining the results of these studies (15 studies), it was found that mortality was higher in patients hospitalized in ICU and general wards, and a significant difference was observed between the average age of recovered and deceased patients. Having high blood pressure as well as diabetes mellitus also significantly led to an increase in mortality. Conclusion: Hospitalization in the intensive care unit, advanced age, high severity of covid-19, high blood sugar and underlying diseases significantly increase the risk of death due to mucormycosis following covid-19.

Keywords

Mucormycosis

Mortality

Risk factor

Patients

Subjects